Dr. Usanee Reinprayoon is an ophthalmologist whose areas of specialization include Comprehensive Ophthalmology, Cornea, and Refractive Surgery. Her clinical work encompasses corneal and external eye diseases, refractive procedures, and a range of conditions affecting the front of the eye. The supplied profiles identify her medical education as an M.D. from the Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Thailand. However, the source materials contain different graduation years: one profile records 1977, while another records 1997. Her specialist qualification is listed as the Diploma of the Thai Board of Ophthalmology, awarded in 2003.

Dr. Reinprayoon completed residency training in Ophthalmology at King Chulalongkorn Memorial Hospital in 2003 and a Clinical Fellowship in Cornea and Refractive Surgery at the same institution in 2005. Another supplied profile describes fellowship training in Cornea and Refractive Surgery at Chulalongkorn Hospital from 2004 to 2005. Her listed subspecialty interests include cornea and refractive surgery, including LASIK and SMILE Pro. The treatments and services in the source include care for corneal and external eye diseases, pterygium and its excision using fibrin glue, keratoconus, refractive surgery, corneal transplantation, and corneal stem cell transplantation.

Her research record includes publications on corneal changes associated with long-term chlorpromazine therapy, allergic conjunctivitis, infectious bacterial keratitis, ocular infections, pterygium recurrence, corneal wound healing, dry eye disease, and other ophthalmic conditions. The supplied materials list multiple peer-reviewed articles published between 2009 and 2020 in ophthalmology and medical journals. Dr. Reinprayoon speaks Thai and English. A separate profile lists a routine clinic schedule at MedPark Hospital on selected Tuesdays, with the location noted as the Eye Care Center, Floor 12A, Counter B; schedules may change and should be confirmed with the hospital.

Educational Qualifications

• M.D., Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand. The supplied profiles report different graduation years: 1977 and 1997.
• Residency in Ophthalmology, King Chulalongkorn Memorial Hospital — 2003.

Fellowship & Areas of Interest

• Clinical Fellowship in Cornea and Refractive Surgery, King Chulalongkorn Memorial Hospital / Chulalongkorn Hospital — 2004–2005.
• Clinical interests and subspecialties: cornea; refractive surgery, including LASIK and SMILE Pro; comprehensive ophthalmology.

Research Contributions & Publications

• Kasetsuwan N, Reinprayoon U, Jariyakosol S. “Corneal changes in long-term chlorpromazine therapy.” Asia Biomed. 2009;3(4):425–431.
• Kasetsuwan N, Chatchatee P, Reinprayoon U. “Efficacy of local conjunctival immunotherapy in allergic conjunctivitis.” Asian Pacific Journal of Allergy and Immunology. 2010;28:237–241.
• Kasetsuwan N, Tanthuvanit P, Reinprayoon U. “The efficacy and safety of 0.5% levofloxacin versus fortified cefazolin and amikacin ophthalmic solution for infectious bacterial keratitis.” Asia Biomed. 2011;5(1):77–83.
• Reinprayoon U, Permpalung N, Kasetsuwan N, et al. “Lagenidium sp. ocular infection mimicking ocular pythiosis.” Journal of Clinical Microbiology. 2013;51(8):2778–2780.
• Reinprayoon U, Maneerat N, Chansangpetch S, et al. “Eye Donation Project: Differences Between Donors Versus Refusers.” International Journal of Eye Banking. 2015;3(1).
• Reinprayoon U, Sitthanon S, Kasetsuwan N, Chongthaleong A. “Bacteriological findings and antimicrobial susceptibility pattern of isolated pathogens from visual threatening ocular infections.” Journal of the Medical Association of Thailand. 2015;98(Suppl 1):S70–S76.
• Kasetsuwan N, Reinprayoon U. “A sodium hyaluronate ophthalmic solution for reducing dry eye and enhancing corneal wound healing after photorefractive keratectomy.” Asian Journal of Pharmaceutical and Clinical Research. 2015;8(2):226–231.
• Chansangpetch S, Manassakorn A, Laksanaphuk P, Reinprayoon U. “Atypical presentation of Mycobacterium tuberculosis uveitis preceding nodular scleritis.” BMC Infectious Diseases. 2015;15(1).
• Kasetsuwan N, Reinprayoon U, Chantaren P. “Descemet’s scroll in syphilitic interstitial keratitis.” International Medical Case Reports Journal. 2015;8:219–223.
• Kasetsuwan N, Reinprayoon U, Satitpitakul V. “Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: A randomized controlled trial.” Clinical Therapeutics. 2015;37(10):2347–2351.
• Kasetsuwan N, Sakpisuttivanit K, Reinprayoon U, et al. “Recurrent rates and risk factors associated with recurrent painful bullous keratopathy after primary phototherapeutic keratectomy.” Clinical Ophthalmology. 2015;9:1815–1819.
• Kasetsuwan N, Reinprayoon U, Satitpitakul V. “Photoactivated chromophore for moderate to severe infectious keratitis as an adjunct therapy: A randomized controlled trial.” American Journal of Ophthalmology. 2016;165:94–99.
• Kasetsuwan N, Satitpitakul V, Puangsricharern V, Reinprayoon U, Pariyakanok L. “Comparison of performances of femtosecond laser and microkeratome for thin-flap LASIK.” Lasers in Surgery and Medicine. 2016;48(6):596–601.
• Tirakunwichcha S, Lerdchanapornchai V, Reinprayoon U, et al. “Prevalence of dry eye disease in autoimmune thyroid disease and the association of dry eye with clinical signs of thyroid associated ophthalmopathy.” Asian Biomed. 2016;10(2):133–138.
• Taechajongjintana M, Kasetsuwan N, Reinprayoon U, et al. “Effectiveness of voriconazole and corneal cross-linking on Phialophora verrucosa keratitis: A case report.” Journal of Medical Case Reports. 2018;12(1):225.
• Satitpitakul V, Ratanawongphaibul K, Kasetsuwan N, Reinprayoon U. “Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: A randomized trial.” Graefe’s Archive for Clinical and Experimental Ophthalmology. 2019;257(6):1289–1294.
• Piyacomn Y, Kasetsuwan N, Reinprayoon U, et al. “Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction: A randomized, double-masked, sham-controlled clinical trial.” Cornea. 2019; and 2020;39(3):325–332 (both years are listed in the supplied source).
• Piyacomn Y, Kasetsuwan N, Puangsricharern V, Reinprayoon U, Satitpitakul V. “Topometric indices and corneal densitometry change after corneal refractive surgery combined with simultaneous collagen crosslinking.” 2019;13:1927–1933.
• Kasetsuwan N, Suwajanakorn D, Tantipat C, Reinprayoon U. “The efficacy between conventional lid hygiene and additional thermal pulsatile system in meibomian gland dysfunction patients treated with long-term anti-glaucoma medications in a randomized controlled trial.” Clinical Ophthalmology. 2020;14:2891–2902.
• Kasetsuwan N, Chantaralawan K, Reinprayoon U, Uthaithammarat L. “Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial.” PLOS ONE. 2020;15(6).
• Reinprayoon U, Jermjutitham M, Tirakunwichcha S, et al. “Conjunctival sporotrichosis from cat to human: Case report.” American Journal of Ophthalmology Case Reports. 2020;20.

Awards, Honours, and Recognitions

• The supplied profile materials do not list specific awards or honours.

Specialization

• Comprehensive Ophthalmology
• Cornea and External Eye Disease
• Refractive Surgery (including LASIK and SMILE Pro)
• Pterygium and pterygium excision with fibrin glue
• Keratoconus
• Corneal transplantation
• Corneal stem cell transplantation

Languages

• English
• Thai

• The supplied profiles identify Dr. Reinprayoon as an ophthalmologist practicing in comprehensive ophthalmology, cornea, and refractive surgery.
• A separate MedPark Hospital profile lists clinic hours on Tuesdays, 17:00–19:00, during weeks 1 and 3, at the Eye Care Center, Floor 12A, Counter B. Appointment schedules should be confirmed with the hospital.